Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ido Wolf

Showing results (101-110 of 128) with videos related to

Pageof 13
Sort By:
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|June 15, 2019
Resection Versus Observation of Small Asymptomatic Nonfunctioning Pancreatic Neuroendocrine TumorsAlex Barenboim, Guy Lahat, Ido Nachmany, et al.
Cardio-Oncology (London, England)|January 11, 2024
Sodium-glucose co-transporter-2 inhibitors in patients treated with immune checkpoint inhibitorsMoran Gvili Perelman, Rafael Y Brzezinski, Barliz Waissengrin, et al.
International Journal of Cardiology|December 8, 2023
The prognostic value of beta-1 blockers in patients with non-small-cell lung carcinoma treated with pembrolizumabYasmin Leshem, Tal Etan, Yardenna Dolev, et al.
Annals of Surgical Oncology|April 22, 2020
Increased Rate of Complete Pathologic Response After Neoadjuvant FOLFIRINOX for BRCA Mutation Carriers with Borderline Resectable Pancreatic CancerTalia Golan, Alex Barenboim, Guy Lahat, et al.
Oncogene|May 7, 2021
Integrase-derived peptides together with CD24-targeted lentiviral particles inhibit the growth of CD24 expressing cancer cellsShiran Shapira, Eynat Finkelshtein, Dina Kazanov, et al.
Nutrients|August 26, 2023
Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II StudyDaniel Keizman, Moshe Frenkel, Avivit Peer, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 5, 2021
Cancer Therapeutics-related Cardiac Dysfunction in Patients Treated With Immune Checkpoint Inhibitors: An Understudied ManifestationShira Peleg Hasson, Joshua Arnold, Ilan Merdler, et al.
Nutrients|December 28, 2021
Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Results of a Prospective Phase II StudyDaniel Keizman, Moshe Frenkel, Avivit Peer, et al.
Cancer Research|November 13, 2013
D538G mutation in estrogen receptor-α: A novel mechanism for acquired endocrine resistance in breast cancerKeren Merenbakh-Lamin, Noa Ben-Baruch, Adva Yeheskel, et al.
Surgical Oncology|August 15, 2024
The effect of long-standing lymphopenia after radiation therapy on survival in rectal cancerViacheslav Soyfer, Eli Lugovoy, Alla Nikolaevski-Berlin, et al.
Pageof 13

Showing results (101-110 of 128) with videos related to

Sort By:
Pageof 13
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|June 15, 2019
Resection Versus Observation of Small Asymptomatic Nonfunctioning Pancreatic Neuroendocrine TumorsAlex Barenboim, Guy Lahat, Ido Nachmany, et al.
Cardio-Oncology (London, England)|January 11, 2024
Sodium-glucose co-transporter-2 inhibitors in patients treated with immune checkpoint inhibitorsMoran Gvili Perelman, Rafael Y Brzezinski, Barliz Waissengrin, et al.
International Journal of Cardiology|December 8, 2023
The prognostic value of beta-1 blockers in patients with non-small-cell lung carcinoma treated with pembrolizumabYasmin Leshem, Tal Etan, Yardenna Dolev, et al.
Annals of Surgical Oncology|April 22, 2020
Increased Rate of Complete Pathologic Response After Neoadjuvant FOLFIRINOX for BRCA Mutation Carriers with Borderline Resectable Pancreatic CancerTalia Golan, Alex Barenboim, Guy Lahat, et al.
Oncogene|May 7, 2021
Integrase-derived peptides together with CD24-targeted lentiviral particles inhibit the growth of CD24 expressing cancer cellsShiran Shapira, Eynat Finkelshtein, Dina Kazanov, et al.
Nutrients|August 26, 2023
Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II StudyDaniel Keizman, Moshe Frenkel, Avivit Peer, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 5, 2021
Cancer Therapeutics-related Cardiac Dysfunction in Patients Treated With Immune Checkpoint Inhibitors: An Understudied ManifestationShira Peleg Hasson, Joshua Arnold, Ilan Merdler, et al.
Nutrients|December 28, 2021
Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Results of a Prospective Phase II StudyDaniel Keizman, Moshe Frenkel, Avivit Peer, et al.
Cancer Research|November 13, 2013
D538G mutation in estrogen receptor-α: A novel mechanism for acquired endocrine resistance in breast cancerKeren Merenbakh-Lamin, Noa Ben-Baruch, Adva Yeheskel, et al.
Surgical Oncology|August 15, 2024
The effect of long-standing lymphopenia after radiation therapy on survival in rectal cancerViacheslav Soyfer, Eli Lugovoy, Alla Nikolaevski-Berlin, et al.
Pageof 13